Pharma Bear Raids: Dendreon And Pozen [View article]
Would love for the following to be picked up by the main print publications as well as Dendreon PR.
IPCC Conference Chair Provenge Survival Advantage 10-11 Months 38 minutes ago <“In fact, if you look at our analysis of the patients who received a frozen product on the control arm and those who did not receive it, there was a significant survival advantage to those patients who did receive the frozen product,” said Gomella. “It made the difference between the control arm and the actual treatment arm much closer. And if you take out those patients who did not receive the frozen product on the control arm, that survival difference actually approaches 10 to 11 months.”>
2 Biotech Stocks Ready To Soar On New Drugs [View article]
Oh yeh, obesity is going away because people can take a pill. This has to be the most moronic statement to date. This is like saying the war on drugs is working.
Can Dendreon Become The 'Next Dendreon?' [View article]
You last name is right on, "WONG" as in "WRONG".
Your statement, "Taken in its entirety, the process is incredibly time and resource intensive, and may restrict Provenge to a small niche of cancer patients." could not be further from the truth. Provenge allows the patient to live their life fully while being administered in a doctors office for 3 short visits. They leave the doctors office after the drug is administered and go play catch with their grandson. What Chemo offers are costs added side affects and overnight hospital stays pushing the costs well over 93k. Once again, do your research by going to the Dendreon's website where you can find all relevant information. Copying and pasting from others really does you no justice.
Dendreon: Following Up On Market Mania [View article]
Thanks Saul for the excellent overview of how an industry with alternative motives and consistent negative press can almost destroy a company. Dendreon has survived and it ultimately will become the destroyer. Once the news breaks of overall survival is actually 1 year + and that Provenge should be administered even earlier than previously thought, the previous high of 57 will be laughable. Keep up the good work as I enjoy reading your articles and Theodore's as well. Long term holder.
5 Drugs That Own The Prostate Pipeline [View article]
It still amazes me that anyone can just put an article out there. You clearly show your lack of knowledge in this field and should probably write about something you have knowledge about. I would be embarrassed that some of your "followers" know more about the options for Prostate Cancer Patients than yourself. I hear Nascar is looking for a beat writer.
Medivation Up 140% In One Day, While Dendreon Gets Quartered [View article]
Can you elaborate on your finding regarding Provenge, " There is also concern from doctors and patients that Provenge does not provide impressive survival benefits." Can you inform us of another FDA Approved drug for Prostate Cancer that shows a better survival benefit? You actually talk to patients whom told you they would rather die early or rather take chemo than Provenge because it does not offer an impressive survival benefit?
Dendreon: The Challenge Of Misinformation [View article]
Saul, why is that Dendreon does not feel the need to defend itself? Educating the Physicians at this point whom already have made the judgement call that Provenge only gives you 4 months more of life and it's wasting money, these physicians are literally killing their patients. Dendreon should be running TV commercials on all networks. It would be well worth the money.
Provenge Reimbursement Already On The Way To A Solution [View instapost]
Well, only time will tell. We shall see the results of the jcode when next earnings are released.
What really concerned me more was when he mentioned there were Doctors out there who did not know what patients are eligible for Provenge? Did Dendreon's sale force not properly educate the medical community on which patients should receive Provenge?
Dendreon Shares Plummet on Cancer Drug Reimbursement Uncertainty [View article]
Let's see how the J-code affects the next earnings in three months. Any sign of this speeding up the reimbursement will settle everyone's nerves. You have to expect kinks on an initial roll-out but I think this caught everyone by surprise.
Buying Dendreon on Thursday's Plunge [View article]
Another journalist expert in biotech. Get your facts straight before you write an article. Well, I guess this is what we should expect from someone making 10k a year to write BS.
Dendreon: Bending the Infamous Cost Curve [View article]
Your statement of Insurance Companies telling patients they will not pay for Provenge is 100% wrong. The issue is at hand are private practice doctors having to pay for the drug up front and worried it will take months to get reimbursed.
Pharma Bear Raids: Dendreon And Pozen [View article]
IPCC Conference Chair Provenge Survival Advantage 10-11 Months 38 minutes ago
<“In fact, if you look at our analysis of the patients who received a frozen product on the control arm and those who did not receive it, there was a significant survival advantage to those patients who did receive the frozen product,” said Gomella. “It made the difference between the control arm and the actual treatment arm much closer. And if you take out those patients who did not receive the frozen product on the control arm, that survival difference actually approaches 10 to 11 months.”>
Pharma Bear Raids: Dendreon And Pozen [View article]
http://bit.ly/J2Lb8W
Pharma Bear Raids: Dendreon And Pozen [View article]
http://bit.ly/J2Lb8W
2 Biotech Stocks Ready To Soar On New Drugs [View article]
Provenge And The Immunodepletion Theory: The Facts [View article]
I wonder what would happen if the same treatment, try to destroy a company, was geared towards say Apple or Google or Goldman Sachs?
Can Dendreon Become The 'Next Dendreon?' [View article]
Your statement, "Taken in its entirety, the process is incredibly time and resource intensive, and may restrict Provenge to a small niche of cancer patients." could not be further from the truth.
Provenge allows the patient to live their life fully while being administered in a doctors office for 3 short visits. They leave the doctors office after the drug is administered and go play catch with their grandson. What Chemo offers are costs added side affects and overnight hospital stays pushing the costs well over 93k.
Once again, do your research by going to the Dendreon's website where you can find all relevant information. Copying and pasting from others really does you no justice.
Dendreon: Following Up On Market Mania [View article]
5 Drugs That Own The Prostate Pipeline [View article]
Medivation Up 140% In One Day, While Dendreon Gets Quartered [View article]
You actually talk to patients whom told you they would rather die early or rather take chemo than Provenge because it does not offer an impressive survival benefit?
Dendreon: The Challenge Of Misinformation [View article]
How Undervalued Dendreon Is [View article]
Provenge Reimbursement Already On The Way To A Solution [View instapost]
What really concerned me more was when he mentioned there were Doctors out there who did not know what patients are eligible for Provenge? Did Dendreon's sale force not properly educate the medical community on which patients should receive Provenge?
Dendreon Shares Plummet on Cancer Drug Reimbursement Uncertainty [View article]
Buying Dendreon on Thursday's Plunge [View article]
Dendreon: Bending the Infamous Cost Curve [View article]
Don't make up stuff. That's bad journalism.